Author of

• 35454

  +

  ES02 - Pro-Con: Do We Need Biomarkers to Guide the Choice of Immunotherapy Treatment? (ID 157)

  • Event: WCLC 2020
  • Type: Educational Session
  • Track: Immunotherapy (Phase II/III Trials)
  • Presentations: 1
  • Moderators:
  • Coordinates: 1/29/2021, 10:30 - 11:30, Scientific Program Auditorium

  • 35455

    +

    ES02.01 - We Should Choose Treatment Based on PD-L1, TMB and Other Biomarkers (ID 3970)

    10:30 - 11:30  |  Presenting Author(s): Ticiana A Leal
    • Abstract
    • Presentation
    • Slides

    Abstract not provided

    Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.